Status:
RECRUITING
Better Birth Outcomes Through Technology, Education, and Reporting
Lead Sponsor:
Ohio State University
Collaborating Sponsors:
American Heart Association
Conditions:
Pregnancy
Maternal Anemia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This is a pragmatic randomized control trial to evaluate the BETTER intervention compared to standard obstetrical care (control) to determine whether it helps to reduce maternal anemia and other adver...
Detailed Description
There are more than 3.5 million births per year in the United States. A substantial portion of these births (approximately 25-30%) occur in the context of significant adverse pregnancy outcomes (APOs)...
Eligibility Criteria
Inclusion Criteria
- Less than 20 weeks and 6 days pregnant upon enrollment
- At least 18 years of age
- Receiving obstetric care at OSU McCampbell Hall or OSU Outpatient Care East
- Singleton pregnancy and fetus with a heartbeat
- English speaking
- Able to receive text messages
Exclusion Criteria
- Has a significant medical condition (eg sickle cell disease) that is a cause of anemia
- Has a plan for transfusion during pregnancy
Key Trial Info
Start Date :
February 26 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
550 Patients enrolled
Trial Details
Trial ID
NCT06261398
Start Date
February 26 2024
End Date
March 1 2028
Last Update
May 15 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University Outpatient Care East
Columbus, Ohio, United States, 43203
2
McCampbell Hall
Columbus, Ohio, United States, 43210
3
The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
Columbus, Ohio, United States, 43210